Dosages for the Phase IIa programme were selected following the successful completion of the double-blind stage of Beckley Psytech’s Phase I study earlier this year, which showed that BPL-003 was well ...
Most depression treatments don't work quickly and are meant to be taken for long periods of time. Sage Therapeutics is developing a fast-acting drug that patients take for two weeks. Dr. Laura Gault ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback